UBS reiterates Buy on Equifax stock, keeps $220 price target
UBS maintained a Buy rating on Equifax (NYSE:EFX) with a $220 price target, citing strong Q3 earnings and an upbeat outlook. The stock is currently at $174.53, with InvestingPro valuing it at $228.97. Equifax's government business grew to $550M in annual contract value, and its records increased 12% YoY. Analysts have mixed views on its performance, with targets ranging from $175 to $217.
How this was made
The 30-second read
Why it matters
The earnings beat and upgraded targets create a bullish catalyst for the stock.
Market read
Strong earnings and analyst upgrades suggest upside for EFX and may influence the credit‑services sector.
What to watch
Potential headwinds from a slowing housing market and regulatory scrutiny of credit bureaus.
Background
Equifax disclosed Q3 2026 results, showing EPS $2.26 vs $2.20 estimate and revenue $1.69 B. Analysts raised price targets to $220, $210, $175, and adjusted others.
Ticker impact
UBS reiterated a Buy rating and kept a $220 price target after Equifax reported Q3 earnings that beat expectations.
likely upward pressure as the market prices in the higher $220 target versus current $174 price.
The earnings beat and multiple analyst target raises provide fresh, material information that can move the stock.
Market effects
Positive earnings may lift the broader credit‑reporting and data‑services sector.
U.S. consumer‑finance stocks could see modest gains.
Limited to markets with exposure to U.S. mortgage and credit data.
Counterpoint
If mortgage rates stay high, revenue growth could stall despite the earnings beat.
Key entities
- companyEquifax Inc.
U.S. credit reporting firm.
- analystUBS
Maintained Buy rating and $220 target.

